University of Miami, Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
NCT Number: NCT00754468
The purpose of this study is to evaluate the treatment effect, depth of injury, and side effects using technology involving the spray of liquid nitrogen through a catheter (CryoSpray AblationTM, "CSA" or "cryospray therapy") onto healthy tissue via esophagogastroduodenoscopy (EGD) using surgical resection specimens from subjects undergoing esophagectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Miami, Florida, 33136, United States
The proposed study is a single center study consisting of no more than 10 subjects who are undergoing scheduled esophagectomy for reasons unrelated to the study. Subjects will be divided into 2 Groups in a sequential fashion based on the time of enrollment (Subject 1 in Group1, Subject 2 in Group 2, Subject 3 in Group1, Subject 4 in Group 2, etc). Potential study subjects will be referred from clinical practice. After entry into the study with written informed consent, subjects will be scheduled for the EGD with cryospray ablation treatment 7 days prior to the expected esophagectomy date.
All subjects will receive narcotic analgesics to control symptoms.
Endpoints related to pathology will be assessed by two independent reviewers, one from the Institution's Department of Pathology, and one from an independent Pathology lab chosen by the sponsor. The reviewers will evaluate the pathology slides to assess maximal extent of depth of injury, side effects, and pathological changes associated with CSA. All reviewers will be blinded to the treatment conditions of the specimens.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cryo Spray Ablation 4 cycles x 10 seconds treatment
Time frame: End of Study
histopathological findings analyzed to determine max depth of injury (mm)
Time frame: End of Study
CSA Medical, Inc.
Industry
A STUDY OF CRYOSPRAY ABLATIONTM USING SURGICAL RESECTION SPECIMENS TO DETERMINE TREATMENT EFFECT, DEPTH OF INJURY, AND SIDE EFFECTS IN THE ESOPHAGUS (CSA Depth 3)
Acronym: ESODOI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02534233
Barrett Esophagus, Barrett's Esophagus
Baltimore, Maryland, United States
View Trial DetailsNCT01293448
Barrett Esophagus, Barrett's Esophagus
Los Angeles, California, United States
View Trial DetailsNCT00747448
Barrett Esophagus, Barrett's Esophagus
La Jolla, California, United States
View Trial DetailsNCT02427269
Barrett Esophagus, Barrett's Esophagus
Chapel Hill, North Carolina, United States
View Trial Details